YAMAMOTO NUTRITION - ENERGAN (tropical)
Food supplement declared in France, decision dated 14 February 2025
YAMAMOTO NUTRITION - ENERGAN (tropical), from YAMAMOTO S.P.A., is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: glycérol 1,500 mg per day, Eau de coco en poudre, dextrine, Chlorhydrate de lysine, Tryptophane. None of the rules we check flags an issue with its declared composition.
- Brand
- not provided
- Food business operator placing the product on the market
- YAMAMOTO S.P.A.
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Powder
- Daily dose
- 42 g par jour
- Intended populations
- Men and women aged 18 and over
- Not recommended (according to the manufacturer)
- Adolescents (under 18)
- Objectives stated by the manufacturer (these are not authorised claims)
- Autre : FONCTION MUSCULAIRE NORMALE
- Flavourings
- TROPICAL
Declaration 7492, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Substances
| Name | Per day |
|---|---|
| glycérol | 1,500 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Eau de coco en poudre | not declared |
| dextrine | not declared |
| Chlorhydrate de lysine | not declared |
| Tryptophane | not declared |
| Méthionine | not declared |
| Thréonine | not declared |
| Phénylalanine | not declared |
| Glycine | not declared |
| Citroflavonoïdes | not declared |
| Créatine monohydrate | not declared |
| L-alanyl-L-glutamine | not declared |
| Taurine | not declared |
| L-valine | not declared |
| L-isoleucine | not declared |
| L-leucine | not declared |
| Citrulline | not declared |
Additives
E160a, E955, E950, E551, E322, E330
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Has the product changed? Photograph the packaging.
Label warnings
NE PAS DÉPASSER LA DOSE JOURNALIÈRE RECOMMANDÉE. LES COMPLÉMENTS ALIMENTAIRES NE DOIVENT PAS ÊTRE UTILISÉS COMME SUBSTITUTS D'UN RÉGIME ALIMENTAIRE VARIÉ. UNE ALIMENTATION VARIÉE ET ÉQUILIBRÉE ET UN MODE DE VIE SAIN SONT IMPORTANTS. TENIR HORS DE LA PORTÉE DES JEUNES ENFANTS. NE CONVIENT PAS AUX FEMMES ENCEINTES ET AUX ENFANTS OU PENDANT DES PÉRIODES PROLONGÉES SANS CONSULTER UN MÉDECIN. CONSERVER DANS UN ENDROIT FRAIS ET SEC, LOIN DES SOURCES DE CHALEUR ET DE LA LUMIÈRE DU SOLEIL. LA FORMATION ÉVENTUELLE DE GRUMEAUX EST DUE À LA PRÉSENCE DE POUDRE DE GLYCÉROL, UNE MATIÈRE PREMIÈRE TRÈS HYGROSCOPIQUE.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Créatine monohydrate
Read the warning, when it applies and the studies cited
Creatine Monohydrate
Route of administration: Oral
Cautions and warnings
When using this product you may gain weight (Volek and Rawson 2004; Bemben et al. 2001; Mihic et al. 2000).
Sources cited by Health Canada (3)
- Bemben MG, Bemben DA, Loftiss DD, Knehans AW. 2001. Creatine supplementation during resistance training in college football athletes. Medicine & Science in Sports & Exercise 33(10):1667-1673.
- Mihic S, MacDonald JR, McKenzie S, Tarnopolsky MA. 2000. Acute creatine loading increases fat-free mass, but does not affect blood pressure, plasma creatinine, or CK activity in men and women. Medicine & Science in Sports and Exercise 32(2):291-296.
- Volek JS, Rawson ES. 2004. Scientific basis and practical aspects of creatine supplementation for athletes. Nutrition 20(7-8):609-614.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a kidney disorder (Pline and Smith 2005; Pritchard and Kalra 1998).
Sources cited by Health Canada (2)
- Pline KA, Smith CL. 2005. The effect of creatine intake on renal function. The Annals of Pharmacotherapy 39(6):1093-1096.
- Pritchard NR, Kalra PA. 1998. Renal dysfunction accompanying oral creatine supplements. The Lancet 351(9111):1252-1253.
- Taurine
Read the warning, when it applies and the studies cited
TAURINE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Lopez Ramon et al. 2007; Seghieri et al. 2007).
Sources cited by Health Canada (2)
- López Ramón Y Cajal C, Ocampo Martínez R, Couceiro Naveira E, Martínez M. Amino acids in amniotic fluid in the 15th-16th weeks of gestation and preterm labor. The Journal of Maternal-Fetal & Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2007;20(3):225-231.
- Seghieri G, Tesi F, Bianchi L, Loizzo A, Saccomanni G, Ghirlanda G, Anichini R, Franconi F. Taurine in women with a history of gestational diabetes. Diabetes Research and Clinical Practice 2007;76(2):187-192. PubMed
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “YAMAMOTO NUTRITION - ENERGAN (tropical): composition and regulation”, https://compoatlas.com/en/supplements/products/7492-yamamoto-nutrition-energan-tropical, updated 15 November 2026.